1. Stanley JR. Pemphigus. In: Freedberg IM, Eisen AM, Wolff A, eds. Fitzpatrick's Dermatology In General Medicine, 5th ed. New York: McGraw-Hill, 1999:654-66.

2. Bystryn JC. Adjuvant therapy of pemphigus. Arch Dermatol 1984;120:941-51.

3. Bystryn JC, Steinman NM. The adjuvant therapy of pemphigus. An update. Arch Dermatol 1996;132:203-12.

4. Ratnam KV, Phay KL, Tan CK. Pemphigus therapy with oral prednisolone regimens. A 5-year study. Int J Dermatol 1990;29:363-7.

5. Hirone T. Pemphigus: a survey of 85 patients between 1970 and 1974. J Dermatol 1978;5:43-7.

6. Block LJ, Caldarelli DD, Holinger PH, Pearson RW. Pemphigus of the air and food passages. Ann Otol Rhinol Laryngol 1977;86:584-7.

7. Lever WF, White H. Treatment of pemphigus with corticosteroids. Arch Dermatol 1963;87:52-66.

8. Ryan JG. Pemphigus. Arch Dermatol 1971;104:14-20.

9. Rosenberg FR, Sanders S, Nelson CT. Pemphigus: a 20-year review of 107 patients treated with corticosteroids. Arch Dermatol 1976;112:962-70.

10. Lever WF, Schaumburg-Lever G. Immunosuppressants and prednisone in pemphigus vulgaris: therapeutic results obtained in 63 patients between 1961 and 1975. Arch Dermatol 1977; 113:1236-41.

11. Fine JD. Management of acquired bullous skin diseases. New Engl J Med 1995;333:1475-84.

12. Aberer W, Wolff-Schreiner EC, Stingl G, Wolff K. Azathioprine in the treatment of pemphigus vulgaris. A long-term follow-up. J Am Acad Dermatol 1987;16:527-33.

13. Lever WF, Schaumburg-Lever G. Treatment of pemphigus vulgaris. Results obtained in 84 patients between 1961 and 1982. Arch Dermatol 1984;120:44-7.

14. Chrysomallis F, loannides D, Teknetzis A et al. Treatment of oral pemphigus vulgaris. Int J Dermatol 1994;33: 803-7.

15. Piamphongsant T. Treatment of pemphigus with corticosteroids and cyclophosphamide. J Dermatol 1979: 6:359-63.

16. Austin HA, Klippel JH, Balow JE et al. Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs. New Engl J Med 1986;314:614-19.

17. Boumpas DT, Austin HA, Vaughn EM et al. Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis. Lancet 1992;340:741-5.

18. Reiner A, Gernsheimer T, Slichter SJ. Pulse cyclophosphamide therapy for refractory autoimmune thrombocytopenic purpura. Blood 1995;85:351-8.

19. Pasricha JS, Thanzama J, Khan UK. Intermittent highdose dexamethasone-cyclophosphamide therapy for pemphigus. Br J Dermatol 1988;119:73-7.

20. Pasricha JS, Khaitan BK, Raman RS, Chandra M. Dexamethasone-cyclophosphamide pulse therapy for pemphigus. Int J Dermatol 1995;34:875-82.

21. Kaur S, Kanwar AJ. Dexamethasone-cyclophosphamide pulse therapy in pemphigus. Int J Dermatol 1990;29:371-4.

22. Fleischli ME, Valek RH, Pandya AG. Pulse intravenous cyclophosphamide therapy in pemphigus. Arch Dermatol 1999;135:57-61.

23. Smith TJ, Bystryn JC. Methotrexate as an adjuvant treatment for pemphigus vulgaris. Arch Dermatol 1999;135:1275-6.

24. loannides D, Chrysomallis F, Bystryn JC. Ineffectiveness of cyclosporin as an adjuvant to corticosteroids in the treatment of pemphigus. Arch Dermatol 2000;136: 868-72.

25. Lapidoth M, David M, Ben-Amitai D et al. The efficacy of combined treatment with prednisone and cyclosporin in patients with pemphigus: preliminary study. J Am Acad Dermatol 1994;30:752-7.

26. Mobini N, Padilla TJ, Ahmed AR. Long-term remission in selected patients with pemphigus vulgaris treated with cyclosporin. J Am Acad Dermatol 1997;36:264-6.

27. Barthelemy H, Frappaz A, Cambazard F et al. Treatment of nine cases of pemphigus vulgaris with cyclosporin. J Am Acad Dermatol 1988;18:1262-6.

28. Krain LS. Pemphigus. Epidemiologic and survival characteristics fo 59 patients, 1955-1973. Arch Dermatol 1974;110:862-5.

29. Werth VP. Treatment of pemphigus vulgaris with brief, high-dose intravenous glucocorticoids. Arch Dermatol 1996;132:1435-9.

30. Chryssomallis F, Dimitriades A, Chaidemenos GC et al. Steroid-pulse therapy in pemphigus vulgaris long term follow-up. Int J Dermatol 1995;34:438-42.

31. Guillaume JC, Roujeau JC, Morel P et al. Controlled study of plasma exchange in pemphigus. Arch Dermatol 1988;124:1659-63.

32. Bystryn JC, Graf MW, Uhr JW. Regulation of antibody formation by serum antibody. II. Removal of specific antibody by means of exchange transfusion. J Exp Med 1970;132:1279-87.

33. Roujeau JC, Andre C, Joneau FM et al. Plasma exchange in pemphigus. Uncontrolled study of ten patients. Arch Dermatol 1983; 119:215-21.

34. Derksen RHWM, Schurman HJ, Gmelig-Meyling FH et al. Rebound and overshoot after plasma exchange in humans. J Lab Clin Med 1984;104:35-43.

35. Tan-Lim R, Bystryn JC. Effect of plasmapheresis therapy on circulating levels of pemphigus antibodies. J Am Acad Dermatol 1990;22:35-40.

36. Turner MS, Sutton D, Sauder DN. The use of plasmapheresis and immunosuppression in the treatment of pemphigus vulgaris. J Am Acad Dermatol 2000;43:1058-64.

37. Harman KE, Black MM. High-dose intravenous immune globulin for the treatment of autoimmune blistering diseases: an evaluation of its use in 14 cases. Br J Dermatol 1999; 140:865-74.

38. Pandya AG, Dyke C. Treatment of pemphigus with gold. Arch Dermatol 1998;134:1104-7.

39. Poulin Y, Perry HO, Muller SA. Pemphigus vulgaris: results of treatment with gold as a steroid-sparing agent in a series of thirteen patients. J Am Acad Dermatol 1984;11:851-7

40. Basset N, Guillot B, Michel B et al. Dapsone as initial treatment in superficial pemphigus. Report of nine cases. Arch Dermatol 1987;123:783-5.

41. Calebotta A, Saenz AM, Gonzalez F et al. Pemphigus vulgaris: benefits of tetracycline as adjuvant therapy in a series of thirteen patients. Int J Dermatol 1999;38: 217-21.

42. Alpsoy E, Yilmaz E, Basaran E et al Is the combination of tetracycline and nicotinamide therapy alone effective in pemphigus? Arch Dermatol 1995; 131 : 1339-40.

43. Enk AH, Knop J. Mycophenolate is effective in the treatment of pemphigus vulgaris. Arch Dermatol 1999;135:54-6.

44. Enk AH, Knop J. Treatment of pemphigus vulgaris with mycophenolate mofetil. Lancet 1997;350:494.

45. Nousari HC, Anhalt GJ. The role of mycophenolate mofetil in the management of pemphigus. Arch Dermatol 1999;135:853-4.

0 0

Post a comment